Merck (MRK) Total Liabilities (2009 - 2026)

Merck has disclosed Total Liabilities across 18 years of filings, most recently posting $82.8 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 24.11% year-over-year to $82.8 billion; the TTM figure through Mar 2026 stood at $82.8 billion (up 24.11% YoY), while the FY2025 annual figure was $84.2 billion, up 84104.0% from the prior year.
• Total Liabilities slipped to $82.8 billion in Q1 2026, from $84.2 billion in the prior quarter.
• Over the last five years, Total Liabilities for MRK reached as high as $84.2 billion in Q4 2025 and fell as low as $100.0 million in Q4 2024.
• The 5-year median for Total Liabilities is $63.8 billion (2022), against an average of $42.1 billion.
• Annual changes were most pronounced in 2023 — Total Liabilities sank 99.6% — and 2025, when it soared 84104.0%.
• A 5-year view of Total Liabilities shows it stood at $600.0 million in 2022, then plunged by 58.33% to $250.0 million in 2023, then tumbled by 60.0% to $100.0 million in 2024, then soared by 84104.0% to $84.2 billion in 2025, then retreated by 1.66% to $82.8 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $82.8 billion, $84.2 billion, and $77.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.